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ABSTRACT 
Genetic re-manipulation of chimeric antibody-binding green fluorescent proteins was 
successfully conducted to create versatile tools for immunological diagnosis. Four chimeric 
GFPs carrying one and two-consecutive sequences of the Fc-binding motif (Z-domain), 
derivative of IgG-binding B domain of Staphylococcal protein A (SpA), at the C-terminus 
were constructed. The chimeric Ab-binding GFPs possessed dual characteristics of both IgG-
binding and activity of fluorescent emission. The chimeric proteins were purified to 
homogeneity using an IgG-Sepharose column. Additionally, a hexahistidine was fused to the 
N-terminal of the GFPZ and GFPZZ to allow a high protein recovery obtained from 
immobilized metal (Ni2+) affinity chromatography (Ni-NTA), and for protein immobilization 
to the sensor surface. Results obtained from the Surface Plasmon Resonance (SPR) revealed a 
high binding affinity (KA) to immobilized human immunoglobulin up to 6.7 and 81.1 (107/M) 
for the GFPZ and GFPZZ, respectively. This affinity constant was raised up to 2-5 times 
higher when the chimeric GFPs harboring hexahistidine residues were captured on the sensor 
chip via metal coordination. The strong binding affinity to IgG of the chimeric GFPs was 
clinically applied to detect the antinuclear antibody. A strong intensity of fluorescence, higher 
than that of the classical fluorescein isothiocyanate (FITC) conjugated system, was 
significantly detected. Moreover, the proteins with double repeats of Fc-binding motif 
(GFPZZ and H6GFPZZ) obviously demonstrated a more intense fluorescent signal than those 
of the single Z domain, which corresponded to the result from SPR. All these findings support 
a high potential for applying such chimeric Ab-binding GFPs for clinical applications. 
 
Keywords: Chimeric Antibody-binding GFP, Surface Plasmon Resonance, Fluorescent 
antinuclear antibody analysis, C-terminus GFP fusion 
 
INTRODUCTION 
 
Green fluorescent protein (GFP) is an 
autofluorescent protein originally isolated 
from the Pacific Northwest jellyfish, 
Aequorea victoria (Shimomura, 2006). It is a 
27 kDa protein that emits fluorescent light 
(λmax = 508 nm) by excitation at 395 nm. 
Neither substrate nor cofactor is required for 
the fluorescent emission. This emission is 
attributed to the presence of an internal 
chromophore, formed by cyclization and 
oxidation of residues Ser65, Tyr66, and 
Gly67 (Cody et al., 1993). Fusion of the GFP 
to various kinds of cellular protein has been 
applied as a reporter for gene expression 
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(Cha et al., 2002; Kain et al., 1995), as a 
marker to study cell lineage during 
development (Raich et al., 1999; Zernicka-
Goetz et al., 1997), and as a tag to localize 
proteins in living cells (Feilmeier et al., 2000; 
Phillips, 2001). 
GFP is a relatively small monomeric 
protein which possesses a unique 
conformation of β-barrel structure in which 
the emission chromophore resides (Phillips, 
1997). Such a compact structure makes GFP 
highly stable in various hazardous conditions 
and resistant to high concentration of 
denaturing agents (Ward et al., 1982). 
Improper folding of the β-barrel structure 
leads to a decrease of GFP stability and a 
diminishing of fluorescent activity. 
Although, researchers have claimed that 
fluorescence of the full-length GFP is not 
significantly affected by fusing of the partner 
protein to either its N- or C-terminus 
(Margolin, 2000; Yang et al., 1996), there are 
studies showing that fusion of some proteins 
to GFP results in a decrease in its 
fluorescence, especially when the protein 
was fused to the N-terminus. In our hands, 
N-terminal fusion not only influences the 
fluorescent activity in certain cases but also 
affects localization of the fusion protein 
(Prachayasittikul et al., 2004; Prachaya-
sittikul et al., 2001). Aoki et al. (1996) and 
Arai et al. (1998) have found that purified 
protein A-GFP and protein G-EGFP contain 
portions of protein without fluorescent 
activity. The fluorescent and non-fluorescent 
forms of such proteins have migrated to 
different locations in SDS-PAGE analysis. 
Sacchetti et al. (1999) have reported that 
fusion of Myc-tag to the N-terminus of GFP 
diminishes folding efficiency of GFP, 
whereas fusion of Sb-tag to the C-terminus of 
GFP results in 3-fold enhanced folding. This 
phenomenon can be explained by the fact 
that the folding of protein is generally started 
immediately after their N-terminus is 
translated. Therefore, fusion of the other 
proteins to the N-terminus may cause 
irregularly folding. 
It has been found that the fluorescence of 
GFP decreases when it has been expressed 
under a pelB signal sequence (Casey et al., 
2000; Lei et al., 1987). Similar evidence has 
also been found in the chimeric protein 
composed of GFP fused to the C-terminus of 
maltose-binding protein (MBP) (Feilmeier et 
al., 2000). Fluorescence has not been 
detected when the chimeric protein is 
translated in conjunction with the MBP 
signal sequence. In contrast, when the signal 
sequence is deleted, the fluorescent activity is 
regained. In certain circumstances, the N-
terminal fusion brings about low protein 
expression (Griep et al., 1999; Morino et al., 
2001). 
In our previous study (Prachayasittikul et 
al., 2005), we constructed the chimeric Fc-
binding GFP, where the double repeat of Z-
domain, a synthetic binding domain derived 
from protein A (Fexby et al., 2004), was 
genetically fused to the N-terminus of GFPuv 
(Crameri et al., 1996). However, a decrease 
in fluorescent activity and a low yield of the 
chimeric protein was revealed. Such effects 
are plausibly encountered via the presence of 
a signal peptide and the fusing location at the 
N-terminus of GFPuv. Therefore, in this 
study, the signal peptide is omitted and we 
have constructed the Ab-binding GFPs by 
genetically fusing one or two consecutive Z-
domains to the C-terminus. Furthermore, a 
hexahistidine tag has been added to allow an 
alternative purification using immobilized 
metal affinity chromatography (IMAC) and 
for metal immobilization on the sensor 
surface of Surface Plasmon Resonance 
(SPR). The feasibility of using these chimeric 
proteins as powerful tools for immunological 
diagnosis has also been explored. 
 
MATERIALS AND METHODS 
 
Plasmids and Bacterial Strains 
Plasmids pEZZ18 and pTrc99A, both 
obtained from GE Healthcare (Uppsala, 
Sweden), were used for the chimeric genes 
construction. The plasmid pTGFPuv 
previously described elsewhere (Fexby et al., 
2004) was used as a source of the gene 
encoding green fluorescent protein. E. coli 
strain TG1 (supE, hsdΔ5, thiΔ(lac-proAB), 
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F’[traD36 proAB+ lacIq lacZΔM15] was 
used for cloning and protein expression. 
 
Enzymes and Chemicals 
Restriction endonucleases were 
purchased from MBI Fermentas (Vilnius, 
Lithuania). T4 DNA ligase and the “Expand 
High Fidelity PCR system” were obtained 
from New England Biolabs (Beverly, MA, 
USA) and Roche (Mannheim, Germany), 
respectively. All other chemicals were of 
analytical grade and commercially available. 
 
Construction of chimeric genes encoding 
chimeric Ab-binding GFPs 
A series of plasmids harboring chimeric 
genes encoding Fc-binding green fluorescent 
proteins was constructed. All cloning 
procedures were performed according to the 
standard protocol described by Maniatis et al. 
(1989). The experiment was initiated by 
construction of a chimeric gene encoding the 
green fluorescent protein carrying a 
hexahistidine at the N-terminal. Briefly, a 
complementary mixture of 0.1 µM of H6_1 
(5′CATGGGTCATCACCATCACCATCAC 
CGGCGCCTGAGCATC-3′) (MWG Bio-
tech). Parts of both primers are identical to 
the Z encoded gene, prim5ZZ includes a 5′ 
overhang containing a SacI restriction site 
(underlined) and prim3ZZ includes a 5′ 
overhang containing a PstI site (underlined) 
as well as a TCA stop codon (reverse 
complementary sequence of TGA). 
Fragments obtained from amplification were 
then separated by agarose gel electrophoresis 
and purified using the QIAquick gel 
extraction kit (Qiagen, Basels, Switzerland). 
The DNA fragments of Z and ZZ encoded 
genes were digested with SacI and PstI and 
individually cloned into the 3′-end of 
hexahistidine-tagged GFP encoded gene in 
the plasmid pTH6GFPuv, resulting in 
plasmids pTH6GFPZ and pTH6GFPZZ, 
respectively. The genes encoding GFPZ and 
GFPZZ were then cleaved from pTH6GFPZ 
and pTH6GFPZZ by KpnI and PstI digestion 
and inserted into a new pTrc99A plasmid 
vector, resulting in plasmids pTGFPZ and 
pTGFPZZ, respectively. The cloning strategy 
of the different GFP constructs is presented 
in Figure 1. The newly constructed plasmids 
were checked for the in-frame fusion by 
DNA sequencing using BigDye terminators 
v3.0 from Applied Biosystems (Warrington, 
UK), according to the supplier’s recom-
mendations. 
GGTACCATCGATG-3′) and H6_2 (5′-
GATCCATCGATGGTACCGTGATGGTA 
TGGTGATGACC-3′), synthetic oligo-
nucleotides obtained from MWG Biotech 
(Ebersburg, FRG), was hybridized at 90C for 
15 min and slowly cooled down to room 
temperature. The hybridized DNA fragment 
containing an NcoI site at the 5′-end and a 
BamHI site at the 3′-end was further inserted 
in between the NcoI and BamHI sites of 
pTrc99A. Since there was an additional KpnI 
site following the hexahistidine sequence, the 
gfpuv gene obtained from pTGFPuv was 
subsequently inserted in between the KpnI 
and PstI sites, resulting in plasmid 
pTH6GFPuv. 
 
Expression and purification of chimeric Ab-
binding GFPs 
Crude protein extracts preparation 
E. coli cells carrying various kinds of 
chimeric gene were grown in 400 ml of LB 
medium (Tryptone 10 g/L, yeast extract 5 
g/L and NaCl 10 g/L) supplemented with 
ampicillin (100 mg/L). The culture was 
incubated at 37C under shaking (150 rpm) 
for 2 hrs. Protein expression was then 
induced upon addition of IPTG to a final 
concentration of 1 mM and the cells were 
further grown at 30C until the late 
exponential phase (16-18 hrs). Cells were 
harvested by spinning at 7,000 g for 5 min, 
re-suspended in an appropriate working 
buffer (TST; 50 mM Tris-HOAc, 150 mM 
NaCl and 0.05 % Tween 20, pH 7.6 or IMAC 
The fragments of gene encoding Fc-
binding domain (Z or ZZ) were obtained by 
PCR amplification using the plasmid 
pEZZ18 as template together with the 
following sense (prim5ZZ_for: 5′-
AAAAGAGCTCGTAGACAACAAATTCA
ACAAAGAAC-3′) and antisense primers 
(prim3ZZ_rev: 5′-AAAACTGCAGTCATTT 
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Figure 1: Diagrammatic representation of gene encoding antibody-binding GFP constructs. 
 
buffer; 0.05 M Na-Phosphate, 0.5 M NaCl, 
pH 7.6), and disrupted by sonic 
disintegration. Cell debris was removed by 
centrifugation at 17,000 g for 15 min. Bulk 
proteins were partially eliminated by heating 
of the crude extracts at 70C for 15 min and 
the denatured proteins were subsequently 
removed by centrifugation at 17,000 g for 15 
min. The clear supernatants were collected 
for further purification. 
Purification of chimeric protein via IgG-
Sepharose affinity chromatography 
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The supernatant, dissolved in TST buffer, 
was applied onto 2 ml of IgG-Sepharose 6 
Fast Flow gel (GE Healthcare) pre-packed in 
a glass Econo-column (1 cm × 10 cm) from 
BioRad Laboratories (Sundbyberg, Sweden). 
Unbound protein was washed out with 20 ml 
TST buffer followed by 4 ml of 5 mM 
ammonium acetate, pH 5.0. The chimeric 
Ab-binding GFPs were then eluted using 0.3 
M acetic acid, pH 3.4 and the collected 
fractions were immediately neutralized with 
an equal volume of 0.5 M Tris-HOAc, pH 
10.0. The green fluorescent fractions were 
pooled and stored at 4C until further analysis. 
Purification of chimeric protein via 
Immobilized Metal Affinity Chromatography 
(IMAC) 
The supernatants of H6GFPZ and 
H6GFPZZ dissolved in IMAC buffer 
obtained after heat treating step were further 
applied onto 2 ml of NTA-agarose gel 
(Qiagen) immobilized with nickel ions (Ni2+-
NTA) pre-packed in a C10 column (1 cm 
×10 cm) using an AC10 adaptor (GE 
Healthcare). The column was washed using 
IMAC buffer containing 12 mM imidazole. 
Elution of chimeric GFPs was performed 
upon addition of 80 mM imidazole dissolved 
in the same buffer. Monitoring of protein 
elution profile was done using a UV detector 
at 280 nm and the different fractions were 
collected in accordance with the absorbance. 
The recovered samples from both 
purification methods were finally dialyzed 
using Spectra/Por tubings (Spectrum 
Laboratories Inc., Rancho Dominguez, CA, 
USA) soaked in 0.01 M HEPES, 0.15 M 
NaCl, pH 7.6. Protein concentrations were 
measured according to the Bradford’s 
method (Bradford, 1976) using “BioRad 
Protein Assay”. 
 
Characterization of chimeric Ab-binding 
GFPs 
Molecular size estimation and fluorescent 
determination using SDS-PAGE 
Protein separation was performed on 12% 
polyacrylamide gels in a discontinuous buffer 
system, as described by Laemmli (1970). 
Samples were mixed with loading buffer and 
applied directly to the gel with or without 
heat denaturation. Molecular size estimation 
and fluorescent determination of the chimeric 
Ab-binding GFPs was performed on the 
SDS-PAGE with and without heat 
denaturation, respectively. 
Investigation of native state of chimeric Ab-
binding GFPs by gel filtration 
The gel filtration column was prepared 
using Sephacryl S-200 superfine (GE 
Healthcare). Gel was resuspended in running 
buffer composed of 10 mM Tris-HCl, 0.15 M 
NaCl, pH 8.0 and packed at 1 ml/min into a 
C16 glass column (1.6 cm × 70 cm) with 
adaptors, generating a bed height of 48.5 cm. 
All samples were run at a flow rate of 0.1 
ml/min, monitored with a UV detector (280 
nm) and collected into 2 ml fractions. Blue-
dextran was used to determine the void 
volume. Lactate dehydrogenase (LDH), 
bovine serum albumin (BSA) (Sigma), 
luciferase and GFPuv were used to calibrate 
the column. Each protein construct was 
individually applied to the gel filtration 
column to determine the molecular mass in 
the native state and to detect the feasibility of 
dimer formation. 
Analysis of fluorescent property of chimeric 
Ab-binding GFPs 
To investigate the fluorescence properties 
of cells expressing GFPuv and of the purified 
proteins, the fluorescence intensities of cell 
suspension and purified protein extracts were 
measured. E. coli harboring plasmids 
pTGFPZ, pTGFPZZ, pTH6GFPZ and 
pTH6GFPZZ were grown in 100 ml flask 
containing 50 ml of LB broth supplemented 
with 100 µg/ml ampicillin and IPTG was 
then added to a final concentration of 1 mM 
at 2 hrs after inoculation. The cultures were 
further incubated at 30C for 18 hrs. Cells 
were harvested and resuspended in Tris-HCl, 
pH 8.0 to the same density (OD600 = 1). The 
measurements were performed in 4.0 ml 
cuvettes containing 3.0 ml of cell 
suspensions. Fluorescence intensities at 508 
nm were measured upon excitation at 400 nm 
using a Fluorimeter system from Photon 
Technology International (West Sussex, 
UK). 
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Fluorescence intensity of the purified 
chimeric Ab-binding GFPs was also 
measured in a similar manner. Specific 
fluorescence activity was further calculated 
as the fluorescence intensity per milligram 
protein. 
 
Biospecific interaction analysis of chimeric 
Ab-binding GFPs 
Binding affinity to immobilized IgG 
molecules on sensor surface 
To characterize the IgG binding affinity 
of all four constructs, the interaction between 
the chimeric Ab-binding GFPs and human 
IgG was investigated in real time using the 
BIACORE 3000 system (Biacore AB, 
Uppsala, Sweden). Human purified IgG 
(DakoCytomation, Glostrup, Denmark) was 
utilized as an immobilized ligand. 
Immobilization was performed using the 
amine-coupling procedure as described 
elsewhere (Johnsson et al., 1991). Briefly, a 
carboxylated dextran layer of the Biacore 
CM5 sensor chip was activated by N-
hydroxysuccinimide (NHS) and N-ethyl-N′-
(3-diethylaminopropyl)-carbodiimide (EDC). 
The IgG solution used for immobilization 
was prepared in 0.1 M sodium acetate, pH 
5.6 to a concentration of 100 nM. A 
background response of approximately 1800 
response units (RU), caused by the 
immobilized molecule, was reached before 
the surface was deactivated using 1 M 
ethanolamine-hydrochloride solution. A flow 
cell, activated and deactivated in the same 
way, but without IgG immobilization, was 
used as reference. The chimeric Ab-binding 
GFPs were diluted in HBS-P buffer (0.01 M 
HEPES, 0.15 M NaCl, 0.005% Surfactant 
P20, pH 7.4) to final concentrations of 200, 
100, 50, 25, and 12.5 nM. One hundred and 
fifty microlitres of each diluted sample was 
injected (30 µL/min) over the immobilized 
IgG surface. The association and dissociation 
rates of GFPZ, GFPZZ, H6GFPZ and 
H6GFPZZ to the IgG ligand were monitored 
and the results were displayed as sensograms. 
The data were subsequently evaluated using 
the BIAevaluation 3.2 software (Biacore). 
The association rate constant (ka), 
dissociation rate constant (kd) and affinity 
constant (KA) were calculated using a 1:1 
Langmuir adsorption model. 
Binding affinity to free IgG molecules in 
solution 
To further determine the binding affinity 
of the chimeric Ab-binding GFPs to free IgG 
molecules, the chimeric H6GFPZ and 
H6GFPZZ were immobilized onto the NTA 
sensor chip via a metal-binding interaction. 
In detail, nickel ions (500 µM in running 
buffer; 0.01 M HEPES, 50 μM EDTA, 0.15 
M NaCl, pH 7.4) were firstly immobilized 
onto the chip by 1 minute injection at a flow 
rate of 10 μl/min. The H6GFPZ or H6GFPZZ 
obtained from IgG-Sepharose purification 
was further immobilized to a level of 
approximately 400 RU. Samples of human 
IgG prepared at 5 different concentrations 
(275, 137.5, 69, 34.5 and 17 nM) were 
prepared in running buffer and injected at a 
flow rate of 30 µl/min. Between each sample 
injection, the chip was regenerated by 30 µL 
of regeneration buffer (0.01 M HEPES, 0.15 
M NaCl, 0.35 M EDTA, 0.005% surfactant 
P20, pH 8.3) at a flow rate of 10 μl/min. The 
BIAevaluation 3.2 software was used to 
evaluate the data and the kinetics constants 
were calculated using a 1:1 Langmuir model. 
 
Evaluation of potential usage of chimeric 
Ab-binding GFPs on fluorescent 
antinuclear antibody (FANA) analysis 
To evaluate the potential usage of 
applying chimeric Ab-binding GFPs for 
immunological diagnosis, fluorescent 
antinuclear antibody (FANA) assay was 
chosen. Cryosections of rat liver were 
prepared onto microscope glass slides and 
kept at -20C until used. Immediately prior to 
the FANA test, the slides were removed from 
the freezer, allowed to warm up to room 
temperature, and air dried. Thirty microlitres 
of serum from patient were applied onto the 
slides. After 30 min incubation at room 
temperature in a moist chamber, the slides 
were washed three times with PBS and 
allowed to dry at room temperature. 
Subsequently, 20 μl of the chimeric proteins 
(1 μM in PBS) was applied to the liver 
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section and incubated at room temperature in 
a moist chamber for an additional 30 min. 
After being washed three times with PBS and 
air dried at room temperature, the slides were 
covered with glycerin and a cover slip. The 
results were observed under a fluorescence 
microscope using an FITC-filter set. The 
negative control was included by performing 
the test in the same manner using the normal 
serum. The test was also performed using an 
FITC-conjugated antibody (DakoCyto-
mation, Glostrup, Denmark) for comparison. 
 
RESULTS AND DISCUSSION 
 
In our previous work, the chimeric Fc-
binding green fluorescent protein (ZZGFPuv) 
was constructed by gene fusion at the N-
terminus of GFP (Prachayasittikul et al., 
2005). However, the low protein expression 
and loss of fluorescence in the secreted 
portion are a major concern. The N-terminal 
extension has been found to decrease the 
fluorescence activity in the fusion of some 
individual proteins to the GFP. This probably 
is caused by the improper folding or 
defolding of the protein (Prachayasittikul et 
al., 2004; Prachayasittikul et al., 2001). 
Moreover, the presence of SpA signal 
sequence has been found to reduce gene 
expression and in some circumstances the 
chimeric protein was ineffectively secreted 
by sec pathway during translocation process 
(Feilmeier et al., 2000). Meanwhile, it has 
been reported by Sacchetti et al. (1999) that 
fusion at the C-terminus provides a better 
folding of GFP, especially when the tag 
protein possesses a stable helix 
conformation. These have motivated us to re-
engineer the chimeric Fc-binding GFPs in 
order to obtain a higher yield of fully 
function chimeric proteins. 
 
Genetic re-engineering of chimeric Ab-
binding green fluorescent proteins 
In the present study, a series of chimeric 
genes encoding chimeric green fluorescent 
proteins carrying one and two-consecutive 
Fc-binding motifs (GFPZ, GFPZZ) at the C-
terminus have successfully been constructed. 
In addition, the H6GFPZ and H6GFPZZ, 
which are identical to those of GFPZ and 
GFPZZ and contain an additional 
hexahistidine tag at the N-terminus of GFP, 
have also been constructed, to assist protein 
purification as well as for immobilization via 
metal-chelation. Strong cellular fluorescence 
could be detected upon exposure of E. coli 
expressing chimeric Ab-binding GFPs to UV 
illumination as represented in Figure 2. This 
finding infers that extension of the peptide on 
the C-termini does not have any significant 
disturbance on the GFP’s fluorescence. 
Levels of protein expression on different 
variants of chimeric Ab-binding GFPs in E. 
coli were also determined. Both the 
fluorescence activities at the cellular level 
and the specific fluorescence of purified 
protein obtained from IgG-Sepharose 
purification were measured (Figure 3). Total 
cellular fluorescence of the cells expressing 
H6GFPZ and H6GFPZZ were approximately 
2.5 times lower than those of the others. 
Meanwhile, a non-significant difference of 
specific fluorescence activity among the 
purified proteins was observed. Our findings 
lend support to the notion that disparity of 
fluorescent emission of cell suspensions 
might be attributable to the variation of 
protein expression level. This was supported 
by findings that the amounts of purified 
protein obtained from 1 litre of culture were 
at 14.1, 18.2, 4.7 and 4.9 mg for cells 
expressing GFPZ, GFPZZ, H6GFPZ and 
H6GFPZZ, respectively. Thus, the presence 
of a hexahistidine tag appears to be 
detrimental to chimeric protein expression. 
However, this limitation can be overcome by 
supplementation of free histidine residue to 
the growth medium (Lilius et al., 1991). 
Our results revealed that the specific 
fluorescence of purified GFPZ, GFPZZ, 
H6GFPZ and H6GFPZZ were approximately 
1.13, 1.91, 0.85 and 0.82 times as compared 
to that of the native GFPuv. More 
importantly, the chimeric GFPZZ exhibited 
3.8 times higher specific fluorescence than 
that of the fluorescent form of ZZGFP (36 
kDa). Such findings are an indication that 
fusion of Z-domains to the C-terminus of 
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GFP can overcome the loss of fluorescent 
activity due to the incomplete or improper 
folding of chimeric GFP derived from N-
terminus fusion. 
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Figure 2: Colony of E. coli TG1 carrying plasmid pTrc99A (A), pTGFPZ (B), pTGFPZZ (C), 
pTH6GFPZ (D) and pTH6GFPZZ (E), observed under UV illumination. 
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Figure 3: Specific fluorescence activity of each chimeric protein (A) and fluorescence level of 
E. coli cells expressing chimeric antibody-binding green fluorescent proteins (GFPZ and 
GFPZZ denoted as chimeric GFPs carrying one and two consecutive Z-domains at C-
terminal, respectively; H6GFPZ and H6GFPZZ denoted as chimeric GFPZ and GFPZZ 
harboring an additional hexahistidine at their N-terminal) (B) were determined. The results 
were normalized by dividing by the highest value of each category. The values represent the 
means calculated from three independent experiments. 
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To further examine the molecular weight 
of chimeric Ab-binding GFPs and the 
tendency to form dimer (Phillips, 1997), all 
the four constructs were individually 
subjected to gel filtration. A standard curve 
for molecular weight determination was 
created using lactate dehydrogenases, BSA, 
luciferase and GFPuv. Estimation of the 
molecular masses of the chimeric proteins 
was calculated from their elution volumes as 
represented in Table 1. The molecular masses 
of protein in the native state were 30.9, 41.7, 
33.9 and 40.7 kDa for the GFPZ, GFPZZ, 
H6GFPZ and H6GFPZZ, respectively. These 
values were in good agreement with the 
calculated values, proving that monomeric 
proteins were all obtained. 
 
Purification efficiency of chimeric proteins 
using IgG Sepharose column vs. 
immobilized metal ion affinity 
chromatography (IMAC) 
All chimeric Ab-binding GFPs possessed 
dual characteristics of both IgG-binding and 
fluorescence properties. They could all be 
purified to homogeniety via IgG-Sepharose 
column while retaining the high fluorescence 
intensity after purification, as seen in Figure 
4. However, elution of the chimeric protein 
from the IgG column requires very low pH, 
which may lead to the disturbance of protein 
function. Therefore, the IMAC was chosen as 
an alternative method due to its mild-elution 
conditions. The IMAC is also low cost and 
applicable for multiple reusage. 
Further experiments were then conducted 
on the efficiency of protein purification via 
IgG Sepharose and IMAC columns charged 
with nickel ions. Results obtained from the 
purification of H6GFPZ and H6GFPZZ using 
both methods are illustrated in Figure 5 and 
Table 2. As seen in Figure 5, the proteins 
were successfully purified to homogeneity 
via the two approaches, in which the majority 
of protein bands were represented at 34.3 and 
40.9 kDa, for the chimeric H6GFPZ (top 
panel) and H6GFPZZ (low panel), 
respectively. It seemed that the purity of the 
chimeric GFPs purified from Ni-NTA was 
slightly lower. However, the IMAC 
purification has been proven to be beneficial, 
as the recovered yields (ca. 69%) were higher 
than that of IgG sepharose purification (ca. 
56%) (Table 2). 
It is noteworthy that a marked decrease of 
fluorescence was found when the protein was 
solubilized in TST buffer. This is most 
probably due to the presence of Tween, 
which may induce the exposure of 
hydrophobic residues buried inside the 
protein molecule and cause destabilization of 
GFP by favoring aggregation. 
In a separate work, we have compared 
the influencing effects which occur during 
the cell lysis processes either via sonication 
or detergent-containing lysing buffer. When 
the extracts were further heat-treated, a 
greater loss of GFP was observed in the 
presence of detergent (data not shown). This 
suggests that the buffering system influences 
the heat durability of the GFP. The 
thermostability of GFPuv at pH 7-8 is more 
intense in phosphate buffer than in the Tris-
HCl (Penna et al., 2004). 
 
Table 1 The molecular mass of chimeric Fc-binding GFPs determined by gel filtration and 
the theoretical molecular mass calculated from amino acid sequences. 
 
Chimeric 
proteins 
Molecular mass (kDa) 
determined by gel filtration 
Theoretical molecular 
mass (kDa) 
 
GFPZ 
 
30.9 
 
33.1 
GFPZZ 41.7 39.8 
H6GFPZ 33.9 34.3 
H6GFPZZ 40.7 40.9 
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1        2       3       4       M                1        2    3       4
- 66.2
- 45.0
- 35.0
- 25.0
- 18.0
 
 
Figure 4: SDS-PAGE of chimeric proteins purified using IgG immobilized affinity 
chromatography. Approximately 3 μg of protein were applied to electrophoresis gel with (left) 
or without (right) heat denaturation. The gel on the left side was stained with Coomassie 
brilliant blue whereas on the right the gel was exposed to UV irradiation. Lane 1, 2, 3, and 4 
represented chimeric GFPZZ, GFPZ, H6GFPZZ and H6GFPZ, respectively, M indicated a 
protein molecular weight marker (MBI fermentas) presented in kDa. 
 
34.3 kDa
40.9 kDa
1    2    3   4    5    6    7    8   9
 
Figure 5: SDS-PAGE demonstrating purification of H6GFPZ (upper gel) and H6GFPZZ (lower 
gel). Lane 2-5 were samples from IMAC and lane 6-9 were from IgG sepharose purification. 
lane 1: molecular weight marker, lanes 2 and 6: heat treated crude extract, lanes 3 and 7: 
unbound protein, lane 4: 12 mM imidazole wash, lane 8: NH4Ac (pH 5.0) wash, lanes 5 and 
9: eluate fraction. 
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Table 2 Purification efficiency of chimeric Fc-binding GFPs via IgG Sepharose and IMAC. 
 
Protein Purification step Total  Total  Specific %recovery Purification
    protein fluorescence  fluorescence   fold 
    (mg) (count/sec)x106 (count/sec/mg)x106     
GFPZ crude extract  193 697 3.6 100 1 
  Heat treatment 38.4 607 15.8 86 4.4 
  IgG sepharose 2.8 488 174.2 70 48.3 
GFPZZ crude extract  226 859 3.8 100 1 
  Heat treatment 45 765 17 89 4.5 
  IgG sepharose 3.5 638 182.3 74 47.9 
  crude extract 82.6 244 3 100 1 
  heat treatment 18.3 218 11.9 89 4 
H6GFPZ IMAC (Ni-NTA) 0.92 167 181.2 68 60.4 
  crude extract 83.4 248 3 100 1 
  heat treatment 16.6 200 12 81 4 
  IgG sepharose 0.75 138 182.6 56 60.9 
  crude extract 84.3 273 3.2 100 1 
  heat treatment 17.6 230 13.1 84 4.1 
H6GFPZZ IMAC (Ni-NTA) 1.15 188 163.6 69 51.1 
  crude extract 84.7 294 3.5 100 1 
  heat treatment 16.4 225 13.7 77 3.9 
  IgG sepharose 1.00 164 163.6 56 46.7 
 
Binding analysis of chimeric Ab-binding 
GFPs towards IgG 
In order to determine the kinetic 
parameters of the binding interaction 
between the chimeric Ab-binding GFPs and 
IgG, a binding analysis using surface 
plasmon resonance was performed. 
Experiments were carried out to include the 
binding affinity to immobilized IgG on the 
sensor surface and to free IgG molecules in 
the solution. Human IgG (hIgG) was 
immobilized onto the sensor surface by 
amino coupling. The chimeric GFPs were 
then individually injected and their 
association and dissociation constants were 
analyzed. For the binding test of free IgG, the 
H6GFPZ and H6GFPZZ were applied as 
ligands and were non-covalently captured on 
the Ni-NTA sensor chip. The binding 
interaction was analyzed upon injection of 
the free IgG molecules into the system. For 
controls, both the GFPuv and the histidine 
tagged GFPuv variant (His6GFP) were tested 
against hIgG. None of the two proteins 
exhibited any affinity towards hIgG (data not 
shown), indicating the necessity of Z domain 
for high specificity achievements. 
As shown in Table 3, the affinity 
constants (KA) obtained from amino coupling 
of the chimeric GFPZ, GFPZZ, H6GFPZ and 
H6GFPZZ were 6.7, 81.1, 2.4 and 60.3, 
respectively. Our findings revealed that the 
chimeric GFP harboring two-repetitive Z-
domains exhibited ten times higher affinity 
towards IgG than a single Z-domain chimera. 
These values are consistent with those 
reported in the literature for the Z and ZZ-
domains (KA = 1.0-10.0 and 10-100, 
respectively) (Fexby et al., 2004; Gulich et 
al., 2000; Tashiro and Montelione, 1995). 
One main reason for the higher affinity 
constant of ZZ is owing to the lower 
dissociation rate, presumably caused by a 
weak interaction between different molecules 
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Table 3 Kinetics binding constants of chimeric Fc-binding GFPs for human IgG 
 ka* 
(105/Ms) 
kd* 
(10-3/s) 
KA* 
(107/M) 
IgG-immobilization    
Z** 0.5-2.0 2.0-10.0 1.0-10.0 
ZZ** 1.0-5.0 0.2-1.0 10-100 
GFPZ  1.1 1.64 6.7 
GFPZZ 1.9 0.23 81.1 
H6GFPZ 0.5 2.00 2.4 
H6GFPZZ  1.4 0.23 60.3 
Metal-immobilization    
H6GFPZ 0.2 0.16 11.4 
H6GFPZZ 0.4 0.03 125.0 
*ka is the association rate constant. kd is the dissociation rate constant. KA is the affinity constant 
described as the ratio between ka and kd. 
**The kinetic parameters of Z and ZZ were obtained from previous studies (Fexby et al., 2004; Gulich 
et al., 2000; Tashiro and Montelione, 1995). 
 
of Z domain or by the second site 
cooperation on the Fc molecule (Jendeberg et 
al., 1995; Jendeberg et al., 1996). In addition, 
it should be noted herein that the 
hexahistidine tagged constructs exhibited a 
small decrease in affinity constant. However, 
this affinity is still satisfactory for further 
applications in immunoassays. 
Results obtained from the NTA chip had 
a much higher affinity than those obtained 
from amine coupling experiments. This high 
affinity resulted from approximately 13 and 8 
times lower dissociation rates (Kd), in 
conjunction with 2.5 and 3.5 times lower 
association rates (Ka), for the H6GFPZ and 
H6GFPZZ, respectively. The difference in Ka 
could be explained by the discrepancy in 
binding orientation. Plausible explanations 
can be drawn from i) the decrease of Ka 
might be due in part to the high accessibility 
of small molecules (H6GFPZ or H6GFPZZ; 
~30-40 kDa) to bind to IgG molecules (~150 
kDa); ii) the difficulty of IgG to bind to the 
chimeric H6GFPZ or H6GFPZZ pointed 
toward the chip surface, since the N- and C-
terminal of GFP are located on the same side 
of β-can (Phillips, 1997). Therefore, the 
occupancy upon binding to immobilized 
metal ions is needed to be taken into account. 
For the lower Kd obtained from the IgG-
immobilized experiment, one plausible 
reason could be the fact that IgG might lose 
part of its binding ability during the amino 
coupling (Johnsson et al., 1995). However, 
non-specific binding to the immobilized 
metal surface is negligible since no binding 
was observed without pre-capturing of GFP 
molecules (data not shown). 
 
Application of chimeric Ab-binding GFPs 
on fluorescent antinuclear antibody 
analysis (FANA) 
To suit an ultimate goal of this study, the 
feasibility of applying the chimeric Ab-
binding GFPs as a powerful tool for detection 
of antinuclear antibodies (ANAs), was 
evaluated. In this study, the chimeric GFPZ, 
GFPZZ, H6GFPZ and H6GFPZZ, were 
individually applied in FANA instead of 
FITC-conjugated anti-human antibodies. 
Results indicated that all chimeric Ab-
binding GFPs could be used as efficiently as 
the FITC-conjugate to detect antinuclear 
antibodies (Figure 6). However, a divergence 
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in fluorescence intensity could be observed 
among different kinds of chimeric GFPs. The 
proteins with double repeats of Fc-binding 
motif (GFPZZ and H6GFPZZ) demonstrated 
obviously more intense and clearer signals 
than those harboring a single Z domain. 
More importantly, it should be noted that the 
chimeric Ab-binding GFPs provided a 
stronger fluorescence intensity than the 
FITC-conjugated antibodies. A negative 
serum of ANAs was applied as a control 
experiment. 
In conclusion, our findings strongly 
support the high potential of using such 
chimeric Ab-binding GFPs as versatile 
reagents for immunological diagnosis. 
Moreover, the following listed notions 
supportively make our chimeric GFPs 
become more attractive and ideal for clinical 
applications: i) the fluorescent signal is 
relatively stable and resistant to 
photobleaching as compared with the FITC-
conjugation system, ii) no special chemical 
or substrate is required for the reaction, iii) 
the sensitivity is sufficient to analyze a low 
level of antibody, iv) the fluorescence 
intensity and the IgG-binding capability are 
extremely stable for long periods of storage, 
at least 2 yrs at -20C, or even exposure to 
repetitive freezing and thawing and v) the 
process is simple and can further be 
developed as a rapid assay in the future. 
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